Correlation Between Orthofix Medical and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orthofix Medical and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orthofix Medical and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orthofix Medical and MaxCyte, you can compare the effects of market volatilities on Orthofix Medical and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orthofix Medical with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orthofix Medical and MaxCyte.

Diversification Opportunities for Orthofix Medical and MaxCyte

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Orthofix and MaxCyte is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Orthofix Medical and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Orthofix Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orthofix Medical are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Orthofix Medical i.e., Orthofix Medical and MaxCyte go up and down completely randomly.

Pair Corralation between Orthofix Medical and MaxCyte

Given the investment horizon of 90 days Orthofix Medical is expected to generate 0.77 times more return on investment than MaxCyte. However, Orthofix Medical is 1.31 times less risky than MaxCyte. It trades about 0.29 of its potential returns per unit of risk. MaxCyte is currently generating about 0.02 per unit of risk. If you would invest  1,618  in Orthofix Medical on August 28, 2024 and sell it today you would earn a total of  286.00  from holding Orthofix Medical or generate 17.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orthofix Medical  vs.  MaxCyte

 Performance 
       Timeline  
Orthofix Medical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Orthofix Medical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Orthofix Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Orthofix Medical and MaxCyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orthofix Medical and MaxCyte

The main advantage of trading using opposite Orthofix Medical and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orthofix Medical position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind Orthofix Medical and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum